机构:[1]Department of Endocrinology and Metabolism, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Center for Diabetes, Shanghai Key Clinical Center for Metabolic Disease, Shanghai, China[2]Institute for Proactive Healthcare of Shanghai Jiao Tong University, Shanghai, China[3]National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China[4]Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, Jiangsu Province, China[5]Department of Endocrinology, Beijing Hospital, Beijing, China[6]Department of Endocrinology, Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Clinical Research Hospital of Chinese Academy of Sciences, University of Science and Technology of China, Hefei, Anhui Province, China[7]Department of Endocrinology, The Affiliated Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China[8]Institute of Metabolism and Endocrinology, Key Laboratory of Diabetes Immunology, Ministry of Education, National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital and the Diabetes Center, Central South University, Changsha, Hunan Province, China[9]Department of Endocrinology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China[10]Department of Endocrinology, Xijing Hospital, Xi’an, Shaanxi Province, China[11]Department of Endocrinology, Peking University First Hospital, Beijing, China[12]Center for Translational Medicine, The Metabolic Diseases Biobank, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China[13]Key Laboratory of Systems Health Science of Zhejiang Province, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, Zhejiang Province, China浙江省肿瘤医院[14]Center for Excellence in Molecular Science, Chinese Academy of Sciences, Shanghai, China
Background To date, comprehensive data on the distribution of chronic kidney disease (CKD), the most prevalent comorbidity in diabetes, among Chinese adults with diabetes is lacking. Additionally, research gaps exist in understanding the association between CKD and cardiovascular health (CVH), an integrated indicator of lifestyle and metabolic control, within a nationwide sample of Chinese adults with diabetes. Methods A nationally community-based cross-sectional survey was conducted in 2018-2020. 58,560 residents diagnosed with diabetes aged 18-74 years nationwide were invited to participate, and 52,000 participants with complete CKD data were included in this study. CKD was identified by the presence of albuminuria (urine albumin-to-creatinine ratio >= 30 mg/g) and/or decreased estimated glomerular fi ltration rate (eGFR, <60 mL/min/ 1.73 m2). The latter was calculated using the CKD-EPI equation incorporating serum cystatin C and creatinine. CVH was evaluated using the " life ' s essential 8" (LE8) score, which ranged from 0 to 100 and included 8 components: diet, sleep duration, physical activity, nicotine exposure, hemoglobin A1c, blood pressure, non-high-density lipoprotein cholesterol, and body mass index. The total LE8 scores were categorized into low (0-49), middle (50-79), and high (80-100) according to the American Heart Association. The associations of albuminuria and decreased eGFR with potential associated factors, including CVH, socioeconomic status, clinical characteristics, sub-regional divisions, comorbidities, treatments, and metabolic controls, were evaluated using survey logistic regression. Findings The weighted prevalence rates (95% CI) of CKD, albuminuria, and decreased eGFR were 32.6% (31.3%- 33.8%), 30.8% (29.6%-32.1%), and 5.5% (5.1%-5.9%), respectively. Among those with CKD, 25.7% had diabetic retinopathy (DR) and 22.3% had cardiovascular disease (CVD). The weighted prevalence rates of albuminuria and decreased eGFR were consistently higher among southern residents, rural residents, and individuals with more severe DR and a history of CVD than their counterparts (all p < 0.05). After adjustment for age, sex, sub-regional division, setting, educational level, annual household income, family history of diabetes, diabetes duration, glucose-lowering treatment, any DR, CVD, and drinking status, the logistic models showed that the odds ratios (ORs) (95% CI) for albuminuria and decreased eGFR were 0.46 (0.42-0.51) and 0.61 (0.55-0.67) for the participants with moderate scores, and 0.14 (0.10-0.21) and 0.28 (0.19-0.41) for those with high scores, compared with those with low total LE8 scores. Furthermore, the restricted cubic spline curves depicted that the disparities in the odds of having albuminuria or decreased eGFR among subpopulations grouped by sex, age, setting, and geographical region, significantly decreased and even disappeared in some cases as the LE8 scores increased. Interpretation Chinese adults with diabetes are heavily burdened by CKD. Optimized CVH is central to reducing CKD risk across different subpopulations. Funding National Key Clinical Specialty, the Chinese Academy of Engineering. Copyright (c) 2025 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
基金:
Technology Committee [19692115900, 17411952600]; Shanghai Municipal Key Clinical Specialty, Shanghai Key Discipline of Public Health Grants Award [GWVI-11.1-20]; Shanghai Research Center for Endocrine and Metabolic Diseases [2022ZZ01002]; National Key Clinical Specialty [Z155080000004]; Chinese Academy of Engineering [2022-XY-08]; National Key Research and Development Program of China [2021YFC2500201]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB38020000, pp 26-30]
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类|1 区医学
小类|1 区卫生保健与服务1 区公共卫生、环境卫生与职业卫生
最新[2025]版:
大类|1 区医学
小类|1 区卫生保健与服务1 区公共卫生、环境卫生与职业卫生
JCR分区:
出版当年[2023]版:
Q1HEALTH CARE SCIENCES & SERVICESQ1PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
最新[2023]版:
Q1HEALTH CARE SCIENCES & SERVICESQ1PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
第一作者机构:[1]Department of Endocrinology and Metabolism, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Center for Diabetes, Shanghai Key Clinical Center for Metabolic Disease, Shanghai, China[2]Institute for Proactive Healthcare of Shanghai Jiao Tong University, Shanghai, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Endocrinology and Metabolism, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Center for Diabetes, Shanghai Key Clinical Center for Metabolic Disease, Shanghai, China[2]Institute for Proactive Healthcare of Shanghai Jiao Tong University, Shanghai, China
推荐引用方式(GB/T 7714):
Jia Weiping,Yu Rong,Wang Limin,et al.Prevalence of chronic kidney disease among Chinese adults with diabetes: a nationwide population-based cross-sectional study[J].LANCET REGIONAL HEALTH-WESTERN PACIFIC.2025,55:doi:10.1016/j.lanwpc.2024.101463.
APA:
Jia, Weiping,Yu, Rong,Wang, Limin,Zhu, Dalong,Guo, Lixin...&Hou, Xuhong.(2025).Prevalence of chronic kidney disease among Chinese adults with diabetes: a nationwide population-based cross-sectional study.LANCET REGIONAL HEALTH-WESTERN PACIFIC,55,
MLA:
Jia, Weiping,et al."Prevalence of chronic kidney disease among Chinese adults with diabetes: a nationwide population-based cross-sectional study".LANCET REGIONAL HEALTH-WESTERN PACIFIC 55.(2025)